Pharma channel feed

Sanofi de­buts glob­al can­cer sup­port pro­gram for em­ploy­ees

Last year
Marketing

Draft 340B re­forms in­clude user fees, clar­i­ty around con­tract phar­ma­cies

Last year
FDA+
Law

Abec­ma sales dis­ap­point again as BC­MA com­pe­ti­tion ramps up, FDA ad­comm looms

Last year
Cell/Gene Tx

Hik­ma to pay $115M in cash, $35M in do­na­tions to set­tle opi­oid claims

Last year
Law

Re­al Hu­mi­ra com­pe­ti­tion may not ar­rive un­til 2026, Ab­b­Vie ex­ecs tell in­vestors

Last year
R&D

For­mer FDA com­mis­sion­ers urge SCO­TUS to pre­serve agency’s reg­u­la­tions of abor­tion pill

Last year
FDA+
Law

Rick Gon­za­lez lays out plan for in­ter­nal can­di­date to take over as Ab­b­Vie's CEO

Last year
People

Re­gen­eron aims to stop mus­cle loss with com­bi­na­tion treat­ment ap­proach in obe­si­ty

Last year
R&D

Un­like Mer­ck, Bris­tol My­ers to fo­cus on bolt-ons af­ter M&A spree

Last year
Deals

Take­da says farewell to CFO, suite of clin­i­cal-stage pro­grams in Q3 up­date

Last year
R&D

Pub­li­cis Health set­tles opi­oid law­suit

Last year
Marketing
Law

Mer­ck high­lights sub­cu­ta­neous de­mand even as Keytru­da sales soar

Last year

Just how low did the gov­ern­ment go with first IRA of­fers? Phar­ma’s not telling

Last year

AGC Bi­o­log­ics hit with 483 for poor dis­crep­an­cy in­ves­ti­ga­tion prac­tices, qual­i­ty con­trol is­sues at Wash­ing­ton site

Last year
FDA+
Manufacturing

Cor­rect­ed: Bi­par­ti­san IRA fix seeks to align small mol­e­cule and bi­o­log­ic ne­go­ti­a­tion pe­ri­ods

Last year

Mer­ck still on the hunt for bil­lion-dol­lar deals, cit­ing Prometheus and Dai­ichi Sankyo as ex­am­ples

Last year
Deals

Due to ‘over­whelm­ing de­mand,’ Sanofi and As­traZeneca’s RSV an­ti­body to be in lim­it­ed sup­ply 

Last year
Manufacturing

Flash back: Astel­las re­turns to the Su­per Bowl with menopause mes­sage

Last year
Marketing

‘120 pages of da­ta’: Roche’s pipeline re­view leads to as­set cuts, but al­so ad­di­tions

Last year
R&D

Up­dat­ed: Mer­ck gives few de­tails on 2024 re­struc­tur­ing plan for man­u­fac­tur­ing net­work

Last year
Manufacturing

‘Watch this evolve’: Sanofi con­tin­ues to talk up its R&D bet as Paul Hud­son wel­comes new CFO

Last year
R&D

Eli Lil­ly dou­bles down on health eq­ui­ty in new cor­po­rate cam­paign

Last year
Marketing

Rul­ing in SCO­TUS mifepri­s­tone case could lead to end­less lit­i­ga­tion, in­dus­try says

Last year
FDA+
Law

Celebri­ty en­dorse­ments lift Idor­sia, Pfiz­er and No­var­tis TV ads to most ef­fec­tive for phar­ma in 2023, analy­sis finds

Last year
Marketing
First page Previous page 73747576777879 Next page Last page
A service from the Financial Times